Aptose Appoints Jotin Marango, M.D., Ph.D. as Chief Business Officer Jun 3, 2019 09:00AM
Roth Capital Transfers Coverage on Aptose Biosciences (APS:CN) (APTO) at Buy May 24, 2019 05:05AM
Aptose Biosciences (APTO) PT Raised to $7 at Roth Capital Jun 29, 2018 08:40AM
Aptose Biosciences (APTO) PT Raised to $6 at Roth Capital Apr 16, 2018 08:51AM
UPDATE: Roth Capital Resumes Aptose Biosciences (APTO) at Buy Oct 23, 2017 07:30AM


Oct 13, 2016 12:05PM Streetinsider.com's Hot Lunchtime Reads 10/13: (TWTR) (ESPR) (SSYS) (APTO)
Oct 13, 2016 11:53AM Roth Capital Affirms Aptose Biosciences (APTO) at 'Buy'; Clinical Hold Update Disappointing, But Positives Remain
Jun 13, 2016 08:06AM Roth Capital Upgrades Aptose Biosciences (APTO) to Buy
Nov 20, 2015 10:05AM Roth Capital Downgrades Aptose Biosciences (APTO) to Neutral
Nov 11, 2015 02:11PM APTO-253 Remains in Focus for Aptose Biosciences (APTO); Roth Affirms at 'Buy'